Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
14.79
+0.29 (2.00%)
Oct 14, 2025, 4:00 PM EDT - Market closed
Orthofix Medical Revenue
Orthofix Medical had revenue of $203.12M in the quarter ending June 30, 2025, with 2.27% growth. This brings the company's revenue in the last twelve months to $809.03M, up 4.84% year-over-year. In the year 2024, Orthofix Medical had annual revenue of $799.49M with 7.08% growth.
Revenue (ttm)
$809.03M
Revenue Growth
+4.84%
P/S Ratio
0.71
Revenue / Employee
$500,637
Employees
1,616
Market Cap
584.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 799.49M | 52.85M | 7.08% |
Dec 31, 2023 | 746.64M | 285.93M | 62.06% |
Dec 31, 2022 | 460.71M | -3.77M | -0.81% |
Dec 31, 2021 | 464.48M | 57.92M | 14.25% |
Dec 31, 2020 | 406.56M | -53.39M | -11.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
OFIX News
- 21 hours ago - Orthofix to Report Third Quarter 2025 Financial Results - Business Wire
- 2 months ago - Orthofix Medical Inc. (OFIX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Orthofix Reports Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 3 months ago - Orthofix to Report Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System - Business Wire
- 5 months ago - Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Orthofix Reports First Quarter 2025 Financial Results - Business Wire